SCHEMBL172988

SCHEMBL172988

C=C(CCc1ccccc1)CN(C)C

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOA P21397 1/20 0.57
▸ MAOB P27338 1/20 0.57
▸ TAAR1 Q96RJ0 1/20 0.50
▸ SIGMAR1 Q99720 2/20 0.48
▸ KMT2A Q03164 1/20 0.47
▸ ALDH1A1 P00352 2/20 0.47
▸ ALOX5 P09917 1/20 0.46
▸ KEAP1 Q14145 1/20 0.45
▸ EGFR P00533 2/20 0.44
▸ AOC3 Q16853 2/20 0.44
▸ TSHR P16473 1/20 0.43
▸ HDAC3 O15379 1/20 0.42
▸ MAPK1 P28482 1/20 0.42
▸ ADRA1A P35348 1/20 0.42
▸ HDAC4 P56524 1/20 0.42
▸ SLC6A3 Q01959 1/20 0.42
▸ HDAC1 Q13547 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ HDAC7 Q8WUI4 1/20 0.42
▸ HDAC2 Q92769 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7269710 0.81 KEAP1 (0.58) MAOAMAOBTAAR1ALDH1A1KEAP1
SCHEMBL18567782 0.79 ALDH1A1 (0.47) MAOAMAOBTAAR1SIGMAR1ALDH1A1
SCHEMBL16808970 0.79 MAOB (0.89) MAOAMAOBALDH1A1TSHRSMN1; SMN2
SCHEMBL18801048 0.78 ALDH1A1 (0.52) MAOAMAOBKMT2AALDH1A1KEAP1
SCHEMBL5694881 0.77 TDP1 (0.54) MAOAMAOBTAAR1ALDH1A1KEAP1
SCHEMBL2163306 0.77 ALDH1A1 (0.61) KMT2AALDH1A1KEAP1HDAC3MAPK1
SCHEMBL8605471 0.77 ALDH1A1 (0.57) TAAR1KMT2AALDH1A1ALOX5KEAP1
SCHEMBL16795814 0.74 TDP1 (0.50) MAOAMAOBTAAR1ALDH1A1KEAP1
SCHEMBL21321719 0.73 FFAR1 (0.46) ALDH1A1EGFRTSHRSLC6A3FFAR1
SCHEMBL12195215 0.73 KEAP1 (0.54) TAAR1KMT2AALDH1A1KEAP1HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1768966-B1 COUMPOUNDS AND METHODS FOR INHIBITING THE INTERACTION OF BCL PROTEINS WITH BINDING PARTNERS INFINITY DISCOVERY INC (US) 2012-03-07 — — EP disclosed
Send feedback